@article{oai:shiga-med.repo.nii.ac.jp:00003153,
 author = {大竹, 玲子 and 山口, 剛 and 貝田, 佐知子 and 竹林, 克士 and 村田, 聡 and 清水, 智治 and 仲, 成幸 and 中多, 祐介 and 大脇, 成広 and 桑原, 理充 and 清水, 猛史 and 谷, 眞至},
 issue = {1},
 journal = {滋賀医科大学雑誌},
 month = {Mar},
 note = {Departmental Bulletin Paper, The aim of this study is to evaluate outcomes of free jejunal autograft after pharyngolaryngoesophagectomy in Shiga University of Medical Science. We have performed free jejunal autograft since 1999. In this study, we enrolled 24 patients who were performed free jejunal autograft after pharyngolaryngoesophagectomy from 2010 to 2016. Twenty-two patients were diagnosed as hypopharynx cancer, one as thyroid cancer, and one as laryngeal cancer. Clinical stages of 19 patients were cStage IV. Twenty patients had neoadjuvant chemotherapy. The end-to-end pharynx-jejunum anastomosis was performed in 12 patients and the end-to-side pharynx-jejunum anastomosis was performed in 12 patients. Oral intake started on postoperative day 12.5±3.6. Four patients (16.7%) had postoperative complication, which were stenosis, wound dehiscence, embolism and minor leak. There was a significant difference in postoperative complication between end-to-end and end-to-side pharynx-jejunum anastomosis. Twenty two patients (91.7%) had enough oral intake at discharge day. These results were comparatively better outcomes in free jejunal autograft after pharyngolaryngoesophagectomy.},
 pages = {97--101},
 title = {当院の下咽頭喉頭食道切除術における遊離空腸再建24症例の検討},
 volume = {30},
 year = {2017}
}